arrow
S

Sizulu Moyo

university of north carolina–chapel hill
H指数:27
被引数:3,446

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial

评估在赞比亚和南非实施普遍检测与治疗策略对艾滋病预防的影响:推广HPTN 071 (PopART)试验的结果

2025-11-260
OAAI
Computer-aided detection of tuberculosis from chest radiographs in atuberculosis prevalence survey in South Africa: external validation and modelled impacts of commercially available artificial intelligence software
2024-09-010
OAAI
Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis
2024-07-013
PRE
A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15-49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys

非洲国家15-49岁妇女的人类免疫缺陷病病毒1型风险评估工具: 15个全国代表性调查的汇总分析

2024-04-242
OAAI
Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys

16个国家糖尿病、吸烟和饮酒与结核病亚临床症状谱的关联: 一项国家结核病患病率调查的个体参与者数据荟萃分析

2023-09-015
OAAI
Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data

2019年撒哈拉以南非洲15个高负担国家的成人HIV-1发病率2015年: 全国代表性数据的汇总分析

2023-03-0120
OAAI
Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey
2022-08-0149
OAAI
Potential Impact and Cost-Effectiveness of Condomless-Sex-Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance
2019-12-1828
OAAI
A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected Adults

新结核病疫苗MVA85A在HIV和/或结核分枝杆菌感染成人中的IIa期试验

2012-04-0181
OA